Compare ZLAB & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZLAB | HTH |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2017 | 2003 |
| Metric | ZLAB | HTH |
|---|---|---|
| Price | $17.58 | $35.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $49.60 | $37.50 |
| AVG Volume (30 Days) | ★ 680.7K | 323.3K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.25% |
| EPS Growth | 38.46 | ★ 51.72 |
| EPS | N/A | ★ 2.64 |
| Revenue | ★ $460,156,000.00 | $152,188,000.00 |
| Revenue This Year | $14.46 | N/A |
| Revenue Next Year | $29.47 | $3.22 |
| P/E Ratio | ★ N/A | $13.47 |
| Revenue Growth | 15.33 | ★ 15.52 |
| 52 Week Low | $15.96 | $27.35 |
| 52 Week High | $44.34 | $40.41 |
| Indicator | ZLAB | HTH |
|---|---|---|
| Relative Strength Index (RSI) | 40.76 | 43.69 |
| Support Level | $17.03 | $33.79 |
| Resistance Level | $19.49 | $35.69 |
| Average True Range (ATR) | 0.60 | 0.75 |
| MACD | -0.16 | 0.02 |
| Stochastic Oscillator | 8.94 | 50.00 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Hilltop Holdings Inc is a Dallas-based financial holding company. The company has three segments: The banking segment includes the operations of the Bank; The broker-dealer segment includes the operations of Securities Holdings,; and the mortgage origination segment is composed of PrimeLending. Majority of revenue is from Broker-dealer Segment.